4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-059570
Options or other derivatives
- Chief Legal Officer acquired 346,901 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stimart Tryn Chief Legal Officer | 2022-12-01 | Grant or award · Share Options (right to buy) | +346,901 | 2,658,381 | D | ||
Loading xslF345X03/doc4.xml…